Home Management Harnessing Patient Power: Strategies for speeding
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Management Harnessing Patient Power: Strategies for speeding
Harnessing Patient Power: Strategies for speeding
Price:
$2 875.00
Quantity
Price
0 - 0
$2 875.00
0 - 0
$2 875.00
Full Title: Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share
Executive Summary
Relationships between the pharmaceutical industry and patient groups have changed drastically during the past two decades, they are no longer restricted to financial contributions to create goodwill, with no expectation of a measurable return for the company. The management report, Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share, outlines the developments in pharma-patient group alliances and provides a guide for maximizing their impact across a range of pharma activities: clinical trial recruitment, product launches, CME programs, disease awareness and education initiatives. Advocacy groups are now more aware of how to leverage their influence, but still seek financial assistance, cutting-edge information about clinical trials, new therapies, professional or technical support, and other in-kind contributions that help them better serve their patient communities. The report uses detailed case studies to pinpoint how pharma companies can convert such relationships into important business tools to meet their corporate objectives.
